Xagenic

Provider of point-of-care molecular diagnostics for infectious diseases

placeToronto, Ontario, Canada calendar_todayFounded 2010 groups45 employees language xagenic.com

Innovation

9 patent families (1 granted) — focus: Chemistry & metallurgy, Physics & computing, Operations & transport, Electricity & electronics; filing pace dormant. Cited 213 times.

YearFilings
20121
20142
20157
20168
20177

Investor mix

10 investors on record; lead investors include BDC, Domain Associates, CTI Life Sciences Fund, ontariocapitalgrowth.ca.

Investor typeCountShare
Venture capital440%
Accelerator & incubator110%
Other / undisclosed550%
Coming soon